Nordicus Partners (NORD) Return on Equity [ROE] (2009 - 2026)
Nordicus Partners (NORD) posted Return on Equity [ROE] of -8.18% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 1.95 percentage points from -6.23% a year earlier and down 1.91 percentage points from the prior quarter.
Powered by 
Analysis
Nordicus Partners (NORD) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Nordicus Partners' Return on Equity [ROE] came in at -6.52%, up 2.95 percentage points from FY2025.
- Annual Return on Equity [ROE] has increased for three consecutive fiscal years, with a five-year change of +5.17 percentage points (FY2021 to FY2026).
- In prior fiscal years, Nordicus Partners' Return on Equity [ROE] was -9.46% in FY2025 (+23.51 pp), -32.97% in FY2024 (+7593.85 pp), -7626.82% in FY2023 (-7419.23 pp) and -207.59% in FY2022 (-195.90 pp).
- The fiscal Q1 2027 figure stands as the lowest quarterly Return on Equity [ROE] since fiscal Q4 2024.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last five quarters, with an average year-over-year change of +44.05 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was fiscal Q4 2024, with a gain of 13641.84 percentage points; the weakest was fiscal Q4 2023, with a drop of 13422.12 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior fiscal quarters was -6.27% (Q4 2026), -7.06% (Q3 2026) and -7.55% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Nordicus Partners | 55.60 Mn | 55.07 Mn | - | -8.18% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.18% |
| Mar 31, 2026 | -6.27% |
| Dec 31, 2025 | -7.06% |
| Sep 30, 2025 | -7.55% |
| Jun 30, 2025 | -6.23% |
| Mar 31, 2025 | -4.90% |
| Dec 31, 2024 | -5.96% |
| Sep 30, 2024 | -4.38% |
| Jun 30, 2024 | -4.49% |
| Mar 31, 2024 | -16.96% |
| Dec 31, 2023 | -158.46% |
| Sep 30, 2023 | -201.49% |
| Jun 30, 2023 | -388.47% |
| Mar 31, 2023 | -13,657.73% |
| Dec 31, 2022 | -5,469.46% |
| Sep 30, 2022 | -3,549.07% |
| Jun 30, 2022 | -2,901.24% |
| Mar 31, 2022 | -236.83% |
| Jun 30, 2021 | -461.54% |
| Mar 31, 2021 | -246.97% |
API Access
Nordicus Partners Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NORD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NORD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NORD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();